RxDoctor Payments Data

Jonathan Martin, MD

Psychiatry · Corbin, KYNPI 1174908230

Payments from drug & device makers

$2,757in general payments, 2019–2025

Across 156 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • AbbVie$270
  • Neurocrine Biosciences, Inc.$219
  • Vanda Pharmaceuticals Inc.$182
  • Teva Pharmaceuticals USA, Inc.$171
  • Johnson & Johnson$140
  • plus $752 from 12 others

What the payments were for

  • Food & beverage$2,757100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,757 in reported general payments places this provider in the 80th percentile of 348 psychiatry providers in Kentucky.

See all psychiatry providers in Kentucky

Medicare billing

Part B allowed, 2024
$31,862
Medicare patients
101
Services billed
289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate52$176,262
IngrezzaValbenazine Tosylate16$136,919
VraylarCariprazine Hcl95$133,991
AristadaAripiprazole Lauroxil17$49,325
Paliperidone ErPaliperidone38$14,948
Aripiprazole118$13,310
BelsomraSuvorexant24$10,433
VyvanseLisdexamfetamine Dimesylate22$8,386
Lisdexamfetamine Dimesylate22$6,808
ConcertaMethylphenidate Hcl11$6,149
Clozapine66$5,194
Divalproex Sodium ErDivalproex Sodium39$5,115
Clomipramine Hcl36$4,409
Desvenlafaxine Succinate ErDesvenlafaxine Succinate44$3,020
Duloxetine Hcl80$2,735

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Concerta$140$182,41163 claims
Neurocrine Biosciences, Inc.Ingrezza$219$136,91916 claims
AbbVieVraylar$270$133,99195 claims
Alkermes, Inc.Aristada$1,022$49,32517 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$11$8,38622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 348 psychiatry providers in Kentucky.

Other psychiatry in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →